Gainers
- Marker Therapeutics MRKR shares increased by 54.3% to $0.51 during Friday's regular session. The current volume of 63.7 million shares is 16959.7% of Marker Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $42.5 million.
- Athenex ATNX stock moved upwards by 50.75% to $0.95. As of 13:30 EST, this security is trading at a volume of 11.1 million shares, making up 997.5% of its average full-day volume over the last 100 days. The company's market cap stands at $115.4 million.
- Progyny PGNY shares rose 40.24% to $41.75. Progyny's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 297.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 billion. As per the press release, Q2 earnings came out yesterday.
- Global Blood Therapeutics GBT shares rose 36.77% to $65.64. As of 13:30 EST, this security is trading at a volume of 9.1 million shares, making up 553.1% of its average full-day volume over the last 100 days. The company's market cap stands at $4.2 billion.
- GH Research GHRS shares rose 27.28% to $15.49. The market value of their outstanding shares is at $805.8 million.
- Selecta Biosciences SELB stock moved upwards by 27.12% to $2.39. As of 13:30 EST, this security is trading at a volume of 5.1 million shares, making up 227.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $362.8 million. As per the press release, Q2 earnings came out yesterday.
Losers
- Quoin Pharmaceuticals QNRX stock fell 58.0% to $5.91 during Friday's regular session. Trading volume for Quoin Pharmaceuticals's stock is 11.5 million as of 13:30 EST. This is 362.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
- Health Catalyst HCAT shares decreased by 36.29% to $11.64. Health Catalyst's stock is trading at a volume of 5.3 million shares as of 13:30 EST. This is 546.2% of its average full-day volume over the last 100 days. The company's market cap stands at $630.7 million. The company's, Q2 earnings came out yesterday.
- Exagen XGN stock declined by 22.72% to $6.42. Exagen's stock is trading at a volume of 60.7K shares as of 13:30 EST. This is 105.1% of its average full-day volume over the last 100 days. The company's market cap stands at $104.2 million. As per the news, the Q2 earnings report came out yesterday.
- Heart Test Laboratories HSCS shares decreased by 18.31% to $2.21. Trading volume for this security as of 13:30 EST is 712.3K, which is 61.4% of its average full-day volume over the last 100 days.
- Cognition Therapeutics CGTX stock declined by 15.56% to $3.04. As of 13:30 EST, Cognition Therapeutics's stock is trading at a volume of 1.7 million, which is 462.3% of its average full-day volume over the last 100 days. The company's market cap stands at $68.6 million.
- Definitive Healthcare DH stock fell 15.28% to $24.85. Trading volume for this security as of 13:30 EST is 1.3 million, which is 225.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in